Introduction
Antibiotics are one of the most widely used groups of drugs used in the treatment and prevention of bacterial infections. Neomycin is a highly water soluble (50 mg/ mL) hydrophilic antibiotic with bactericidal properties against Gram negative bacteria and partially against Gram positive bacteria and usually used as an antimicrobial for the treatment of gastrointestinal infections and hepatic encephalopathy. 1 It belongs to aminoglycoside class of antibiotics with two or more aminosugars connected by glycosidic bonds and is available in various dosage forms such as creams, ointments and eye drops. Aminoglycosides cause misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth through binding to the bacterial 30S ribosomal subunit (Fig. 1) . 1, 2 Serum albumins (SAs) are the major soluble proteins in the circulatory system that acts as a depot and also a carrier for many endogenous and exogenous compounds such as drugs. [3] [4] [5] Bovine SA (BSA) is the most frequently used protein in the drug-protein interaction studies due to its structural homology with human SA (HSA), cheapness, easy availability and considerable stability. 6, 7 It is a large monomeric protein (66 kDa) consisting of about 583 amino acid residues as single chain. The chain is made up of three homologous but structurally distinct *Corresponding author: Mohammad-Reza Rashidi, Email: rashidi@tbzmed.ac.ir
SPR measurements
All kinetic parameters were recorded with dual flow channels SPR device that uses the Kretscheman prism configuration (MP-SPR Navi 210A, BioNavis Ltd, Tampere-region, Finland).
BSA immobilization through amino coupling
BSA immobilization on the CMD Au chip was carried out as follows: after inserting CMD Au chip on SPR instrument, the whole device was rinsed with acetate buffer (10mM, pH 4.5). After attaining steady baseline in sensorgram, the chip surface was cleaned with NaCl (2M) and NaOH (0.1M) by injecting them to both channels for 3 minutes at flow rate of 30 μL/min. The chip surface was activated by mixing 0.05 M NHS and 0.2 M EDC (1:1) and injecting the mixture solution into the instrument at flow 30 μL/ min for 7 minutes. For immobilization of BSA, its solution was injected (0.3 mg/mL) to channel 1, for 7 minutes and the acetate buffer was injected as the running buffer to channel 2 (reference channel). Finally, ethanolamine-HCl (1.0M) solution was injected to the CMD chip surface for blocking the non-specific binding. 17, 19, 20 Kinetic analysis of immobilized BSA interaction with neomycin Various concentrations of neomycin (1-128 µM) in PBS buffer were injected at a flow rate of 30 µL/min for 3 minutes at pH 7.4. Since BSA was immobilized at one flow cell, both flow cells were used for sample injection and the flow cell without any BSA was used as reference. Regeneration process was not essential due to rapid dissociation of neomycin from BSA surface. The degree of neomycin binding to BSA was determined through measuring the SPR signal at the end of the dissociation phase.
Trace Drawer TM for SPR Navi TM was used for the rate constants, affinity and kinetic calculations of BSA interaction with neomycin. Before calculations in Trace Drawer, data was extracted with SPR Navi TM Data viewer software.
Thermodynamic analysis
The effect of temperature on neomycin binding to BSA was investigated to obtain the thermodynamic parameters of neomycin-BSA complex formation. SPR measurements were carried out at four different temperatures (298, 303, 308 and 313°K).
domains (I-III); each consisting of 2 subdomains (A and B). Drug binding to SA leads to a decrease in the free drug concentration and meanwhile an increase in the drug halflife. As this is the unbound fraction of a drug that exhibits biological activity, its binding to SAs can significantly alter the pharmacokinetics and pharmacological properties of the compound. Therefore, understanding the pattern and mechanism of the interaction of a drug with SA would be extremely important for clinical care and evaluation of the optimum dose and clearance of drug from the body.
As a hydrophilic antibiotic, neomycin has a low serum protein binding and, depending on the methods used for testing, its binding may be between 0% and 30%. 8, 9 Therefore, the study of its SA interaction kinetics could be a challenging issue and the development of a fast and reliable analytical method that allows the measurement of neomycin-albumin interaction kinetics would be of great value. There are various methods for ligand-protein interaction studies such as UV-Vis, fluorescence and circular dichroism (CD) spectroscopy. [10] [11] [12] Surface plasmon pesonance (SPR) is a surface-sensitive label-free technique that offers voluble information about molecular interactions, 13, 14 characterizing binding reactions, 6 measuring reaction kinetics, [15] [16] [17] thermodynamic parameters, 16 affinity constants, 18 etc with high sensitivity. Owing to these properties and abilities, SPR technology has rapidly become a standard tool within the pharmaceutical and biotechnology industries. It is possible to achieve a real-time monitoring and analysis of drug-protein interactions by SPR technology which makes it possible to obtain more detailed information about the binding process, such as the association and dissociation reaction kinetics. This information would be of great value in structure/activity relationship (SAR) studies within the drug discovery process. There is also no need for drug labeling for SPR studies; this not only reduces the time required for samples preparation for analysis but also removes the concern that a tag may alter the binding properties. In addition, it is possible to use the SPR sensor chips for several cycles of analysis without compromising their functionality, which is a desirable feature for high throughput screening studies.
The aims of the present study were to investigate the kinetic and thermodynamic interaction of neomycin with BSA using a SPR based method and to evaluate the ability of SPR to study the interaction of a drug with a low affinity to a protein. In addition, the binding sites of neomycin on BSA were estimated using molecular docking studies. Molecular docking study Molecular docking was carried out to estimate the binding sites in BSA. Herein, the known x-ray 3D structures of BSA and neomycin were extracted from pdb entry 4OR0 and 5IQE, respectively. The docking of neomycin into BSA was performed with the program AUTODOCK 4.2 Release 4.2.6. The lamarckian genetic algorithm (LGA) was used to perform an automated molecular docking. Default parameters were used, except for the number of generations, energy evaluations, docking runs, and maximum number of retries which were set to 27 000; 25 000 000; 200 and 10 000 respectively. A number of grid points in xyz were 126*126*126 separated by 0.7 Å at the middle of the protein. 21 
Results

BSA immobilization
Schematic illustration of successful immobilization of the BSA through amine coupling on the sensor chip surface is shown in Fig. 2 . After activation of carboxylic groups via EDC/NHS, BSA was adsorbed onto the CMD chip through covalent amide binding as described previously. 22 Finally, for blocking the unreacted sites of the surface, ethanolamine was used. Sensorgram measurements of these steps are shown in Fig. 3 . As it is shown, the immobilization level and response unit (RU) of BSA at pH 7.4 were appropriate and acceptable. The immobilization process was further supported by indicating the shift in angular resonance after BSA immobilization. Fig. 4 shows the SPR curve of neomycin interaction with BSA at different concentrations ranging from 1 to 128 µM. Each concentration was injected to the immobilized BSA surface and the SPR signal was used for calculation after reference subtraction. For elimination and reducing of mass transport effect that results in inaccurate data, BSA molecule was immobilized at the low concentration and the flow rate of kinetic tests was set at a higher rate of 30 µL/min. 23 Dose-response sensorgrams were produced for the neomycin interaction with BSA confirming the results obtained from other methods such as spectroscopic (UV/ 
Neomycin-BSA interaction
Kinetics of BSA binding to neomycin
G H T S ∆ = ∆ − ∆
The values of ΔH, ΔS and ΔG between neomycin and BSA interaction are presented in Table 2 , which represent the type of reaction force. Negative values for both ΔH and ΔS were attained for interaction of BSA with neomycin.
Molecular docking study
Molecular docking was used in order to identify the potential neomycin binding sites on BSA structure. The resulting docking energy and number of clustered neomycin conformations were provided in Table 3 and Fig.  5 . Neomycin has capability to interact with all subdomains of BSA but most of the clustered neomycin (114 ligands) was found to be located in the A-site pocket corresponding to cleft of domain IA and IIA (Fig. 5) . The orientation and H-bond interactions of the lowest estimated free energy of binding in first cluster of neomycin (-7.81 kcal/mol) were represented (Fig. 5) . Besides, the attained results showed that ASP residues play a main role in the interaction of neomycin with BSA cleft between domain IA and IIA (Fig. 6 ).
Discussion
The SPR technique can be used for the investigation of protein structure change and protein-ligand complex formation. In the present study, we showed that the SPR signal enhanced upon increasing neomycin concentrations which approved the interaction of neomycin with BSA. The attained kinetic study results indicate that the mean K D value for neomycin binding decreased almost 44.56 fold, from 22.1 µM to 0.496 µM over this temperature range. The temperature dependence of the K D was due to a larger increase in the k a value rather than the k d value. About 140-fold increase in the k a value was observed when temperature increased from 25°C to 40°C. However, there was only 3-fold increase in the k d value when temperature increased from 25°C to 40°C. Overall, the results of kinetic study showed that interaction of BSA with neomycin increases upon rising temperature. 6, 30 The force of interaction between BSA protein and neomycin may be one of the following forces: hydrogen binding, Van der Waals, electrostatic, and hydrophobic forces, which can be estimated through thermodynamic parameters. If ΔH > 0 and ΔS > 0, the main forces are hydrophobic forces, the negative value of both ΔH and ΔS (ΔH < 0 and ΔS < 0) is demonstrative of Van der Waals interactions and hydrogen bonds occurring and finally, if ΔH < 0 and ΔS > 0, the electrostatic interactions may be dominated. 31, 32 Negative values of both ΔH and ΔS indicated that the BSA interacts with neomycin via Van der Waals interactions and hydrogen bonds. Besides, the positive value of ΔG showed that the binding process was non-spontaneous and entropy driven and the formation of neomycin-BSA complex was an endothermic.
BSA is able to bind various ligands in several binding sites (I, II and III, which has two (A and B) subdomains). a The lowest docking-energy conformation was included in the largest cluster found. The rmsd-tolerance was applied at 5.0 Å. The exact BSA binding site for neomycin was cleft between subdomains IA and IIA. The results of this study showed that hydrogen bond is dominated force between BSA and neomycin due to the presence of hydrophilic amino acids such as aspartic acid.
11,33
Conclusion
In this work, we studied the interaction between BSA and neomycin and its related kinetic and thermodynamic parameters using SPR method. Kinetic study showed that the affinity of neomycin to BSA was high enough, which was confirmed by low value of K D . The results of thermodynamic parameters showed that the dominant forces between neomycin and BSA were Van der Waals and hydrogen bond forces due to hydrophilic characteristic of drug. Moreover, binding process is endothermic and entropy driven due to the positive value of ΔG. Molecular docking study confirmed that the dominated force between BSA and neomycin was through hydrogen bond due to the presence of hydrophilic amino acids at binding site of BSA.
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